Biao Gao
Changhongjie, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 18, 2025
Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma.
Journal: Journal of translational medicine
Published: July 11, 2024
Single-cell RNA sequencing reveals intratumoral heterogeneity and multicellular community in primary hepatocellular carcinoma underlying microvascular invasion.
Journal: Heliyon
Published: April 18, 2024
Identification and validation of inflammatory subtypes in intrahepatic cholangiocellular carcinoma.
Journal: Journal of translational medicine
Published: March 13, 2024
Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Journal: Frontiers in immunology
Published: December 05, 2022
Cellular senescence affects energy metabolism, immune infiltration and immunotherapeutic response in hepatocellular carcinoma.
Journal: Scientific reports
Published: September 24, 2022
Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Journal: Functional & integrative genomics
Published: September 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026